0001179110-16-022254.txt : 20160328 0001179110-16-022254.hdr.sgml : 20160328 20160328171954 ACCESSION NUMBER: 0001179110-16-022254 CONFORMED SUBMISSION TYPE: 3/A PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20150429 FILED AS OF DATE: 20160328 DATE AS OF CHANGE: 20160328 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Blueprint Medicines Corp CENTRAL INDEX KEY: 0001597264 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 38 SIDNEY STREET, SUITE 200 CITY: CAMBRIDGE STATE: MA ZIP: 02139 BUSINESS PHONE: 617-374-7580 MAIL ADDRESS: STREET 1: 38 SIDNEY STREET, SUITE 200 CITY: CAMBRIDGE STATE: MA ZIP: 02139 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Lengauer Christoph CENTRAL INDEX KEY: 0001638469 FILING VALUES: FORM TYPE: 3/A SEC ACT: 1934 Act SEC FILE NUMBER: 001-37359 FILM NUMBER: 161533004 MAIL ADDRESS: STREET 1: BLUEPRINT MEDICINES CORP. STREET 2: 215 FIRST STREET, SUITE 340/350 CITY: CAMBRIDGE STATE: MA ZIP: 02142 3/A 1 edgar.xml FORM 3/A - X0206 3/A 2015-04-29 2015-04-30 0 0001597264 Blueprint Medicines Corp BPMC 0001638469 Lengauer Christoph C/O BLUEPRINT MEDICINES CORPORATION 38 SIDNEY STREET, SUITE 200 CAMBRIDGE MA 02139 0 1 0 0 Chief Scientific Officer Common Stock 188332 D Stock Option (Right to Buy) 1.485 2023-11-03 Common Stock 35227 D Stock Option (Right to Buy) 1.87 2024-08-14 Common Stock 24848 D Stock Option (Right to Buy) 8.800 2025-02-10 Common Stock 53408 D Table II, column 3 of the Form 3 filed on April 30, 2015 (the "Original Form 3") inadvertently included an aggregate of 24,696 shares underlying stock options, which the Reporting Person had previously exercised. These shares were also inadvertently omitted from Table I, column 2 of the Original Form 3. The Reporting Person previously filed an amendment to the Original Form 3 on May 1, 2015 reporting the beneficial ownership of an aggregate of 188,332 shares of common stock in Table I, including the 24,696 shares omitted from Table I, column 2 of the Original Form 3. This amendment is being filed to reduce the aggregate number of shares underlying derivative securities reported in Table II, column 3 of the Original Form 3 by 24,696 shares. These shares were also inadvertently included in the aggregate number of shares underlying derivative securities reported in Table II, column 9 of a Form 4 filed by the Reporting Person on February 5, 2016. This option vests in 48 equal monthly installments beginning on November 1, 2013. This option vests in 48 equal monthly installments beginning on August 18, 2014. This option vests in 48 equal monthly installments beginning on February 10, 2015. /s/ Christine Bellon, Attorney-in-Fact 2016-03-28